FDA Issues Warning Letter To Company Selling CBD Products With Unproven Health Claims

The U.S. Food and Drug Administration (FDA) has sent a warning letter to Curaleaf, a company that markets cannabidiol-based products using “unsubstantiated” health claims. Continue Reading →

Sign Up for the Harlem World Newsletter